Mission Statement, Vision, & Core Values (2026) of Procter & Gamble Health Limited.

As a focused arm of a global household-name, Procter & Gamble Health Limited channels P&G's long heritage-founded in 1837-into delivering trusted health and hygiene solutions across markets, leveraging P&G's presence in more than 180 countries to scale innovation and quality; PGHL.NS's mission to improve lives "now and for generations to come" underpins strategic priorities that drive leadership in sales, profit and value creation, while its vision to be recognized as the best consumer products company frames ambitions around brand reputation and consumer trust, and a core set of values-Integrity, Ownership, Passion for Winning and Trust-shapes daily decisions, accountability and sustainable product development that together propel market expansion and long-term consumer loyalty

Procter & Gamble Health Limited (PGHL.NS) - Intro

• Parent company scale: Procter & Gamble (global) generates tens of billions in annual revenue, enabling PGHL.NS to access global procurement, innovation labs and distribution networks.
• Geographic footprint: PGHL.NS commercializes products across multiple markets with a focus on India and selected emerging markets, benefiting from P&G's existing dealer, retail and e-commerce channels.
• Category focus: OTC & wellness, personal hygiene, maternal/infant care, oral care and sanitization products tailored to local consumer needs.

• Customer-centric product development with evidence-based efficacy and clear safety profiles.
• Accessibility: expanding retail and e-commerce reach to underserved urban and rural consumers.
• Affordability: tiered SKUs and pack sizes to meet diverse purchasing power.

• Drive category leadership in defined segments (e.g., oral health, feminine hygiene, OTC wellness).
• Use digital and omnichannel reach to increase household penetration and frequency of use.
• Innovate for sustainability-reduce packaging waste and improve product lifecycle impact.

• Quality & Safety - uncompromising standards for product efficacy and compliance.
• Consumer Respect - listening to needs and designing inclusive solutions.
• Innovation - investing in evidence-led R&D and rapid product iteration.
• Sustainability - lowering environmental footprint across packaging, ingredients and logistics.
• Ethical Business - transparency, regulatory compliance and responsible marketing.

• Market Expansion - grow retail distribution points and e-commerce share year-over-year.
• Product Innovation - targeted pipeline conversions (new SKUs and reformulations) driven by consumer insights and clinical validation.
• Profitability - margin improvement through scale, procurement synergies and premiumization strategies.
• ESG & Social Impact - reduce single-use plastic in packaging and increase accessibility programs for low-income groups.

• Revenue diversification - health & hygiene categories often show resilient demand in economic cycles.
• Margin enhancement - premium SKUs, higher repeat purchase rates and subscription/e-commerce models lift gross and operating margins.
• Brand equity leverage - trusted global brands adapted to local price points and regulatory frameworks.

Procter & Gamble Health Limited (PGHL.NS) - Overview

• Core mission emphasis: superior quality and value for consumers today and for future generations.
• Strategic outcome sought: leadership in sales, profit and shareholder value through consumer preference and loyalty.
• Sustainability embedded: product design and supply‑chain choices guided by a multi‑decade view of environmental and social impact.

• Consumer‑first R&D: invest to solve everyday health and wellness needs with clinically credible, high‑quality offers.
• Brand equity & pricing power: leverage trusted brands to sustain margins and reinvest in innovation.
• Operational scale & efficiency: use global scale to optimize cost, distribution and accessibility.
• Long‑term stewardship: align product lifecycles and packaging with circularity and lower carbon goals.

• Vision: be the most trusted global consumer health partner - measurable through repeat purchase rates, market share growth and NPS improvements.
• Value creation model: invest in innovation, premium positioning and omnichannel reach to convert consumer trust into sustained revenue and margin expansion.
• Sustainable growth: embed lifecycle thinking to reduce environmental footprint while unlocking efficiency gains and enhancing brand reputation.

• Consumer Respect - decisions grounded in measurable consumer benefit and safety.
• Integrity - transparent claims, evidence‑based product positioning and regulatory compliance.
• Excellence in Execution - scale, supply reliability and quality control to protect brand trust.
• Innovation with Purpose - R&D aimed at meaningful health outcomes and improved daily living.
• Stewardship - commitment to sustainability targets and long‑term community impact.

• Sales growth vs. category and country benchmarks (market share delta)
• Repeat purchase rate and net promoter score (NPS)
• Gross and operating margin trajectory
• Percentage of packaging recyclable/reusable and absolute GHG emissions reductions vs baseline
• R&D spend as % of sales focused on health outcomes

Procter & Gamble Health Limited (PGHL.NS) - Mission Statement

• Innovation: sustained R&D investment targeting clinically supported health and hygiene solutions (formulation upgrades, delivery systems, safety improvements).
• Market expansion: targeted distribution growth across urban and rural channels in India and selective export markets.
• Operational efficiency: supply‑chain optimization and manufacturing scale to reduce per‑unit cost and improve margins.
• Brand reputation: evidence‑based marketing, regulatory compliance, and third‑party certifications to strengthen consumer trust.

• Science and evidence: clinical validation and continuous product safety monitoring.
• Accessibility: multi‑channel availability (retail, e‑commerce, institutional) and affordability strategies.
• Quality and compliance: adherence to national and international regulatory standards and GMP.
• Sustainability: reducing environmental footprint across packaging, ingredients, and manufacturing.
• People and culture: talent investment, training, and ethical governance to sustain innovation.

• Product pipeline: launch 8-12 new SKUs annually focused on clinical differentiation and consumer need gaps.
• Distribution expansion: increase rural penetration by 20% over 3 years through supply-chain partnerships.
• Sustainability targets: reduce plastic intensity by 15% and manufacturing water use by 10% within 5 years.
• Profitability: improve adjusted EBITDA margin by 200-500 basis points via mix, pricing, and cost programs.

• Regulatory compliance: systematic audits and product dossiers aligned with CDSCO/other relevant regulators.
• Quality assurance: batch-level traceability and independent lab validation to minimize recall risk.
• Reputation metrics: Net Promoter Score (NPS) and brand equity measurements integrated into executive KPIs.
• Financial discipline: capital allocation focused on SKU profitability, digital investments, and working capital efficiency.

• Revenue growth drivers: premiumization, geographic expansion, and e‑commerce share gains.
• Margin drivers: scale, product mix, and supply‑chain efficiency.
• Capital allocation lens: reinvest in high-ROIC innovations and maintain disciplined leverage targets.

Procter & Gamble Health Limited (PGHL.NS) - Vision Statement

• Consumer-first innovation: developing clinically substantiated, easy-to-use health products that address clear unmet needs.
• Accessibility and reach: expanding distribution channels to serve urban and rural consumers with affordability and consistency.
• Sustainability and responsibility: embedding environmental, social, and governance (ESG) criteria into product design, sourcing, and operations.

• Integrity: We always try to do the right thing - ensuring product safety, regulatory compliance, transparent reporting, and ethical marketing.
• Leadership: We are all leaders in our area of responsibility, with a deep commitment to delivering leadership results - setting category standards, driving best practices, and mentoring rising talent.
• Ownership: We accept personal accountability to meet our business needs, improve our systems, and help others improve their effectiveness - end-to-end accountability across product lifecycles and P&L stewardship.
• Passion for Winning: We are determined to be the best at doing what matters most - relentless focus on consumer outcomes, market share gains, and operational excellence.
• Trust: We respect our P&G colleagues, customers, and consumers, and treat them as we want to be treated - fostering collaborative relationships with suppliers, retailers, clinicians, and communities.

• Balanced scorecard: financial (revenue, EBITDA margin), consumer (penetration, repeat purchase rates), operational (OTIF, working capital days), and ESG (waste reduction, responsible sourcing) measures.
• Transparent disclosures: regular investor updates, regulatory filings, and stakeholder communications that reflect both short-term performance and long-range strategy.
• Continuous improvement: structured kaizen and cross-functional reviews to convert learning into faster product launches and efficiency gains.